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Abstract
Research into adrenal insufficiency (AI) and congenital adrenal hyperplasia (CAH) in children has focused largely on clinical
consequences for patients; and until recently, the wider experience of the condition from the perspective of other family members
has been neglected. In a mixed methods study, we captured the experiences of parents of young children affected by AI/CAH,
including their views on the psychosocial impact of living with and managing the condition. Semi-structured interviews were
carried out in the UK and an online survey was developed, translated and disseminated through support groups (UK and the
Netherlands) and outpatient endocrinology clinics (Germany). Challenges associated with diagnosis, treatment, support and the
future were identified. For UK parents, the diagnosis period was characterised by a lack of awareness amongst healthcare
professionals and occurrences of adrenal crisis. Parents reported burden, anxiety and disruption associated with the intensive
treatment regimen. Parents adjusted and gained confidence over time yet found delegating responsibility for medication difficult
and worried about the future for their child. Access to psychological support and contact with other families was reported as
highly beneficial. The findings of the study provide critical context for future studies and for informing how parents and families
can be better supported. Prenatal genetic counselling for parents who already have an affected child will include an explanation of
recurrence risk but should also focus on providing information and reassurance about diagnostic testing and care for their
newborn.
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Background
Adrenal insufficiency (AI) is a rare condition in which the
adrenal glands are unable to produce the essential stress hor-
mone cortisol (Charmandari et al. 2014). Before the introduc-
tion of cortisol replacement therapy in the 1950s, death in an
adrenal crisis and cardiovascular collapse was inevitable.
Even with cortisol replacement, patients with AI may undergo
adrenal crisis, usually precipitated by infection, and still have
twice the mortality of the healthy population (Bancos et al.
2015). AI is classified as primary or secondary; the most com-
mon cause for primary AI in children is congenital adrenal
hyperplasia (CAH) which results from the inheritance of a
mutation in an enzyme that controls production of cortisol.
As a result of the low cortisol levels, the pituitary gland over-
stimulates the adrenal glands causing hyperplasia and overse-
cretion of androgens, which cause ambiguous genitalia and
virilisation in female infants, precocious puberty in both boys
and girls and infertility in adults. Patients with primary AI
including CAH may also be deficient in aldosterone which
is important for controlling salt balance (‘salt-wasting’ CAH
is severe and can be fatal; symptoms appear within days or
weeks of birth).
A recent review identified that current research in CAH still
has a strong emphasis on potential health complications, emer-
gency management and consequences of excess androgen ex-
posure, whilst the management of CAH from the perspective
of the family has been neglected (Fleming et al. 2017a).
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Previous studies have highlighted a number of challenges
associated with living with AI and CAH, particularly in rela-
tion to treatment. Although two recent studies focusing on the
health-related quality of life and functioning of children with
CAH found that they experience few negative side effects
(Halper et al. 2017; Sanches et al. 2012), it has previously
been argued that health outcomes for adult patients are im-
paired in part because of the treatment they received in child-
hood (Arlt et al. 2010; Finkielstain et al. 2012; Hahner et al.
2007; Han et al. 2014; Løvås et al. 2002). Yet, there is a lack of
consensus on management approaches (Han et al. 2014), pre-
senting challenges to clinicians (Kim et al. 2012) and patients
have reported difficulties such as remembering to take the
medication and balancing doses with busy lifestyles (Forss
et al. 2012). Patients and families are also responsible for
adaptingmedication to avert adrenal crisis, for example during
illness or stress (so-called sick day rules). Whilst treatment for
adrenal crisis is highly effective, there is evidence that there is
insufficient education about it for patients, and improvements
in education could significantly reduce morbidity and mortal-
ity (Allolio 2015).
Recent studies have also highlighted inadequacies in infor-
mation and support provided to parents post-diagnosis (Boyse
et al. 2014): in preparing them for managing adrenal crisis
(Fleming et al. 2017b); in communicating genetic risk to other
family members (Abad et al. 2017); and in learning how to
cope, make sense of their new situation and talk to their child
(Lundberg et al. 2016). Research studying the parental expe-
rience of childhood illness is important as parents often take
on the role of mediator and intermediary, particularly between
the child patient and the professional (Hummelinck and
Pollock 2006); they play a crucial role in how children adjust
and manage illness (Aytch et al. 2001); and they underpin the
well-being of the family unit (Fisher 2001). In the context of
AI/CAH, given the critical nature of the treatment regime,
researching the experience of parents is even more fundamen-
tal to understanding the full illness experience and identifying
how the whole family can be better supported. Existing re-
search points to the importance of information and support
particularly in the first 5 years after diagnosis (Fleming et al.
2017b), suggesting that focusing on the experiences of parents
of younger children is especially important.
We undertook a mixed methods study focusing on the ex-
periences of parents of young children affected by AI/CAH in
the UK, the Netherlands and Germany, including their views
on the psychosocial impact of living with and managing the
condition. It aimed to (i) capture the experiences of parents
through semi-structured qualitative interviews and (ii) further
explore the emerging themes and related issues with larger
numbers of parents through an online survey. This paper fo-
cuses on describing the key challenges experienced by parents
and discusses the implications of these findings for healthcare
professionals, including genetic counsellors supporting
parents after diagnosis and providing prenatal counselling
for parents with an affected child.
Methods
The study used a mixed methods approach in two phases:
qualitative semi-structured interviews followed by an online
survey designed to capture both quantitative and qualitative
data.
Phase 1: Qualitative Semi-Structured Interviews
Qualitative interviews were conducted with parents in the UK.
The interviews were semi-structured, encouraging parents to
disclose a full and rich account of their experiences (Smith et
al. 2009) at the same time as allowing the researcher to main-
tain a focus and guide the interview, rather than dictate its
direction (Bold 2012). Interview questions were open (‘tell
me about…’) and designed to gain a better understanding of
parents’ experiences and the psychosocial impact of AI/CAH,
from diagnosis to the present. The interview topic guide, in-
formed by findings from the initial literature review, included
diagnosis, treatment, impact, information and support and
hopes and concerns for the future. A pilot interview was con-
ducted with a parent of a child with CAH—the parent was
British but was living outside of the UK at the time. Parents
were recruited via the Living with CAH support group in the
UK using a purposeful sampling strategy. Purposive sampling
is a non-random approach, often used by qualitative re-
searchers to identify and select participants who meet certain
criteria. Recruitment material (an advert and information
sheet) was disseminated to potential participants via newslet-
ters, members’ news alerts and websites, inviting parents to
contact the research team. Parents (both mothers and fathers)
of children aged 10 and younger were included in the sample.
Those parents whose children were aged over six were asked
to focus on their earlier experiences (i.e. their child’s first
6 years of life). Interviews took place between September
and December 2014. A small number of the interviews were
conducted with both parents present, although typically just
one parent chose to take part. The majority of interviews took
place within the family’s home and lasted approximately 1
hour.
The interviews were transcribed verbatim by a professional
transcribing company who had signed a confidentiality agree-
ment. Transcripts were read and checked for accuracy. The
transcripts were then analysed thematically by a member of
the research team (AS) with the support of assisted qualitative
data analysis software, NVivo 8. A number of strategies can
help researchers to achieve analytical depth (Ziebland and
McPherson 2006). The coding structure developed over time,
as data were coded under both anticipated themes (such as
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those identified in the literature and those included in the topic
guide) and new emergent themes. Following the initial steps
in the analysis process, in order to clarify the main topics
under each overarching theme, all of the coded data were
exported to theme-specific files and a further round of analysis
was conducted. A second member of the research team (AH)
checked the coding structure and the data coded against it.
Research teammembers AS and AHmet regularly throughout
the data collection and analysis stages of the study to discuss
and clarify emerging themes. Findings were also discussed
with a wide range of stakeholders including parents and pro-
fessionals of different disciplines (via project steering group
meetings and conferences), providing the opportunity to con-
sider a variety of insights and interpretations.
Phase 2: Online Survey
The interview approach allows for participants to talk at length
about their journeys and offer a more in-depth account of their
experiences, including how their experiences may change or
improve over time. Contrastingly, surveys capture a snapshot
of views at the time point of completing the survey. We de-
veloped an online survey to further explore the anticipated and
emerging themes and related issues with a larger number of
respondents. This manuscript focuses specifically on items
assessing parents’ experiences included in the larger online
survey which also examined the impact of CAH/AI on chil-
dren and use of health services/other types of care.
The survey was disseminated to parents of children with AI
(including CAH) under the age of six in the UK, the
Netherlands and Germany. The decision to pilot, translate
and disseminate the survey in these countries was a pragmatic
one based on available resources and existing links with active
patient groups and endocrinologists.
The coding framework developed during interview analy-
sis formed the basis of the survey development. Open and
closed questions were included to explore a range of key is-
sues including those related to getting a diagnosis, the psycho-
social impact of living with the condition, support and aware-
ness, surgery and treating and monitoring the condition.
Existing published survey tools were assessed but were found
not to meet the aims of the study. Members of the research
team (AS, AH, RR, MJW and SD) contributed to the formu-
lation of the research questions. The survey was developed
and piloted initially in English with a small number of parents
in the UK. Feedback from the parents on the English survey
helped to validate content, test parents’ interpretation of ques-
tions and to assess the feasibility of completing the survey.
The survey was then translated into Dutch and German,
checked for language accuracy and piloted by native speakers:
a parent in the Netherlands and an endocrinologist in
Germany. As such, both also had knowledge of AI and
healthcare provision in those countries.
The survey was distributed via patient and parent support
groups including the Living with CAH Support Group (UK),
the Addison’s Disease Self-Help Group (UK) and the Adrenal
NVACP Association (Netherlands). In addition, the survey
was advertised via paediatric endocrinologists and their out-
patient clinics in Germany. The survey was live for a period of
8 months (July 2015 to February 2016), to allow time for the
material to cascade to individuals. Interviewees were not ex-
cluded from completing the online survey and due to the an-
onymity of survey responses it was not possible to determine
whether they had. As a result of the recruitment method
adopted, it was not possible to calculate a response rate. Due
to the sample size, the survey analysis was exploratory and
mainly descriptive in nature. Statistical analysis software,
SPSS, was used to support the analysis.
Results
Phase 1: Interview Findings
In total, 16 interviews took place, with 20 parents (14 mothers
and six fathers) of 17 children (nine female and eight male).
All interviewees were based in the UK. The majority of par-
ents had children aged 6 or younger at the time of the inter-
view (ages ranged from 3 months to 10 years). Three parents
with children over the age of 6 took part and were asked to
focus on their experiences during the child’s first 6 years of
life.
A number of challenges for parents of children with AI
were identified during transcript analysis. These challenges
relate to the anticipated themes of the interview topic guide:
diagnosis, treating and managing the condition, thinking
about the future and practical and emotional support. The
themes and subthemes are summarised below and shown with
representative quotes in Table 1.
Diagnosis
The interviews shed light on parents’ experiences prior to and
during the diagnosis period. Parents faced challenges associ-
ated with clinicians’ low awareness of CAH and some strug-
gled to convince general healthcare professionals (e.g. general
practitioners and health visitors) of the significance of their
child’s symptoms; they had to ‘fight’ for a diagnosis. There
were also reports of differences between professionals and
hospitals (particularly in relation to awareness of the condi-
tion) and inadequacies in the way that the diagnosis (or poten-
tial diagnosis) was given to families. For some parents, their
child’s diagnosis was only made as a result of the child going
into adrenal crisis.
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Table 1 Interview findings: themes, subthemes and representative quotes
Theme Subtheme Quote
Diagnosis Struggle to convince
healthcare professionals
‘I had to really fight for my child for this diagnosis and it’s such an incredibly
complex condition’.
Variation in awareness ‘I think we’ve been very lucky because she was born at an excellent hospital –
I know it’s incredibly rare but they might see three cases a year whereas if she
was born in a remote hospital they won’t see any cases probably and they
won’t know what on earth’s going on’.
Inadequate communication ‘When the consultant came up, you know, he printed off some sort of page of
information off the internet of possible conditions it could be and it was a bit
of a scrappy piece of paper with a list of about ten conditions, all of which
were awful, and I didn’t want them to be any of those… CAH was on there
and it was, sort of, like, well if it’s…not treated it can be fatal, so I remember
reading those words… and that wasn’t nice, I would have preferred to have
had a nice booklet with a picture of a friendly face on the front’.
Adrenal crisis before diagnosis ‘…the kind of slap round the face for me and the only thing that upset me about
the whole experience was when that doctor said 20 minutes later and he
probably would have died… if he’d been in 20 minutes later he might not have
made it. And that brought it home’.
Treating and managing
the condition
Medicating correctly
i. Anxiety
‘I think it’s just practically it’s just the hassle of having to get his medication ready
and you can never forget it, you know, you can never forget it. So I think that
adds stress. Not buckets of stress but just you’re always thinking right when’s
the next time, when’s the next time. And so there’s a, kind of, latent anxiety’.
Medicating correctly
ii. Difficulties preparing doses
‘I think when you’re already a bit traumatised and looking after a new baby, having
to chop tablets up into little bits and having to -, we had to dissolve them in a
little bit of sterilised water as well when he was tiny and all that sort of faffing
around, you could really, really do without. And especially when you’re worrying
whether you’ve got the quantities right and you know the tablets you’ve quartered
yourself are not accurately quartered and by the time you’ve dissolved it and
you’ve left a bit in the pot’.
Medicating correctly
iii. Timing of doses
‘We’re shattered! I am always tired! It’s tiring and [she] I think is tired because even
if she goes back to sleep it’s just a disturbed sleep isn’t it and I know it’s not as
important for me but I go to bed every night thinking oh God I’ve got to get up
at half five and that’s just horrible, because half five…’
Delegating care BI mean I’ve got no intention of going back to work because what child minder in
their right mind is going to look after him? They’re going to take one look at
his sheet and think ‘I don’t think so’.^
Disruption of family life ‘I think if the hospital visits had been where it was locally that would have made
a big difference to me because it was really hard being a new mum, you’ve got a
little baby and then you’re having to put them in a car, travel 2 hours to an
appointment, have the appointment not knowing what it’s going to be or bring
up in there, travel 2 hours back, my little girl had to go into family childcare again
so that’s me feeling like I’m abandoning my 4 year old again. And it’s not really
what new mums do’.
A new routine ‘I can’t honestly, don’t even think I’ve ever forgotten to give it to him, you know,
we just sort of base it into our routine. I think probably he was so young, it probably
helped us and probably helped him, I mean, he’s grown up with the medicine and
it’s one of those things where we just sort of got used to it as part of a new routine’.
Thinking about
the future
Taking responsibility ‘...but I do have a lot of concern when he’s out of our immediate control when he
grows older, you know, we do know stories of students when they go away to
university, you know, literally going out getting drunk forgetting all about their
medication and dying...’
Developing normally ‘…you read about all of the horrible things. In my worst case scenario [she’s] going to
be... obese, she’s going to be really hairy, she’s going to have psychological issues...’
Relationships ‘I worry about the future in terms of...She’s never going to be able to have children.
She’ll be like –...Never be able to have sex, you know all of like worst things’.
Life-long medication ‘...when we found out about [his] condition, one of the first thoughts was, you know,
he’s not going to be able to do that [travel] so freely, he’s not going to have that
freedom because he’s always going to be tied down to getting back somewhere to
have his hydrocortisone or his fludrocortisone which needs to be refrigerated’.
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Treating and Managing the Condition
Parents provided a wealth of data about their experience of
treating and managing the condition. The following sub-
themes emerged during analysis.
Medicating Correctly Interviewees argued that much of the
burden was associated with having to get the right dose of
medication to their child, at the right time. This was intensi-
fied by three factors: the importance of dosing correctly; the
practical difficulties in preparing the medications; and the
frequency/timing of dosing.
First, parents were aware of the importance of achieving
the optimum medication levels to avert both long-term poor
health outcomes and the threat of adrenal crisis during illness
or stress. Parents not only had to follow routine medication
regimes, they were also responsible for recognising when to
adapt and adjust the medication during illness or stress (‘sick
day’ rules). Second, the way in which the medication (partic-
ularly the hydrocortisone) had to be prepared and adminis-
tered was a contributing factor. Interviewees reported it to be
inconvenient and they shared their concerns that their child
was not getting the optimum dose of medication each time.
Third, the medication was required frequently throughout the
day, often starting with an early morning dose.
Interviewees provided detailed accounts of the general disrup-
tion and anxiety that they experienced in relation to the medica-
tion regime. A lot of the data relate to the constant management
required: parents do not get a day off from their caring role. They
described ‘another layer’ to parenting and a ‘latent anxiety’.
Delegating Care Interviewees described the concerns and dif-
ficulties they faced in delegating treatment responsibility to
childcare agencies and schools, including the responsibility to
‘train’ staff and the emotional impact of incidents where med-
ications were not given correctly. Parents reported giving up
work in order to delay or manage the transition of care to others,
as their child became old enough to join nursery or school.
Disruption of Family Life Frequent medical appointments, of-
ten requiring significant travel, are a major source of disruption
for families in terms of the time they take up and the impact
this can have on siblings and the affected child’s school life.
A New Routine Interviewees provided detailed accounts of
their established routines and a narrative of their experiences
as they adjusted to their new caring roles. For example, par-
ents talked about the challenges of leaving the supportive
environment of the hospital and getting to know and under-
stand their newborn babies. Our findings suggest that skills,
knowledge and confidence very much developed over time.
Thinking About the Future
Parents reported feeling worried about their child’s future.
First, parents had concerns about the possible long-term
Table 1 (continued)
Theme Subtheme Quote
Surgery ‘I worry about the future in terms of...In my worst case scenario...she’s going to
have surgery; if she has surgery it will go wrong’.
Different to peers ‘...she does look different and as she gets older I just think other children and
teenagers and everyone worries about their body anyway don’t they and then
you’ve got this extra thing to worry about and I think, yeah, it worries me as
she gets older, how she is going to deal with it’
Adult health services ‘I got the impression then that in the UK the care for children with this disease...
is excellent, and then they kind of get lost, so once they become adults a lot of
people just sort of disappear and presume they just carry on taking the same
medication, but they’re not really in touch with the medical professions’.
Practical and emotional
support
Sources of support
i. Healthcare professionals
‘...you have your trials and tribulations with it, but then you have to take it into
the outside world and deal with it on that level and I guess that’s why they use
a psychologist because they want to support you in how you cope with surgery,
decisions, medicine and all of that’.
Sources of support
ii. Support groups/peer
support
‘I went out to meet up with her [mother of an affected boy] and her little boy is six
and I have to say that was a godsend doing that, just to see a normal little – I
think that might have been a turning point actually from when he became a
baby as opposed to just CAH’.
Gaps in support ‘...it’s the emotional and practical support that you get in that first year that I
didn’t get and I managed because he was the third child...and I understood
the condition or made myself understand the condition. What really worries
me is what happens when there’s a parent who isn’t like that and doesn’t
get support, what happens to them?’
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effects of the condition and medication. They worried about
whether their child would grow and develop ‘normally’ and
whether they would be able to have children. Second, parents
had concerns about how their child would cope with surgery
and medication. For example, parents worried about their
child being reliant on medication for the rest of their lives
and their child taking on responsibility for their own treatment
(when they move away from the family home). Parents
expressed their concerns about how girls bornwith ambiguous
genitalia would cope psychologically as they get older and as
they become more aware of their condition. Third, parents had
concerns about the transition from paediatric to adult health
services. Finally, parents did not want their child to grow up
feeling different from their peers.
Practical and Emotional Support
Interviewees talked about various sources of practical and
emotional support that they have found helpful, and about
times when they recognised their own support needs were
not being met. Parents discussed the support in the context
of coming to terms with the diagnosis themselves, making
complex decisions about surgery and communicating details
about the condition to others. For example, parents identified a
tension between being completely open and honest about the
condition and giving too many details about ambiguous gen-
italia, surgery and treatment.
Healthcare professionals such as psychologists and special-
ist nurses are valued for the support they offer beyond the
supervising doctors. Being able to make contact with other
families, for example through support groups (online forums
or organisations that facilitate face to face events), had been a
very important—even pivotal—source of support for inter-
viewees. Parents still face unmet needs for practical and emo-
tional support. For example, interviewees cited a lack of ac-
cess to psychological services and a lack of knowledge of the
condition amongst local health teams. Around the time of
diagnosis, families can be far removed from networks of fam-
ily and friends because of the need for care at specialist
centres.
Phase 2: Survey Findings
In total, 57 survey responses were received from parents (the
vast majority were mothers (75%, 43/57)) of children aged 6
or below. Similar numbers responded from the UK, the
Netherlands and Germany. There were three responses from
participants living in other countries: one from the USA, one
from New Zealand and one undisclosed. These responses are
included in the findings presented below, except where we
make comparisons between European countries, where they
are excluded. In response to the question ‘what is the cause of
your child’s adrenal insufficiency?’, the majority (79%, 45/57)
of participants stated CAH; 4% (2/57) reported hypopituita-
rism; 2% (1/57) reported autoimmune adrenalitis; 2% (1/57)
did not know the cause of their child’s AI; and 14% (8/57)
selected ‘other’. The majority of those with CAH (91%, 41/
45) reported that their child had been diagnosed with classic
salt-wasting CAH. Of the respondents’ affected children 31/
57 (54%) were male, 25/57 (44%) were female and one child
was registered as intersex/indeterminate gender on their birth
certificate. The survey results reported here relate to those
themes and subthemes identified in the interview phase and
outlined above. Because of the small numbers of respondents,
analysis is restricted to descriptive statistics. However, where
the data suggest an interesting contrast (for example between
countries) then this is discussed.
Diagnosis
Data shows that diagnosis wasmade quickly in the majority of
cases (see Table 2), with 79% (45/57) reporting that their child
was diagnosed before they were 2 weeks old. Yet differences
across the three countries can be observed in relation to the
diagnosis experience.
None of the children of the respondents living in the UK
were diagnosed by newborn screening, whereas 70% (14/20)
of those living in the Netherlands and 50% (9/18) of those
living in Germany had received the diagnosis this way. In
addition, the most common initial symptoms or complications
experienced by the children prior to diagnosis were ambigu-
ous genitalia (28%, 16/57) and dehydration/salt loss (25%, 14/
57), and a quarter of respondents (25%, 14/57) reported no
symptoms or complications prior to diagnosis. Those who
reported no symptoms or complications were exclusively
from non-UK countries. In contrast, 38% (6/16) of parents
living in the UK reported that adrenal crisis was their child’s
initial symptom or complication, compared to only 10% (2/
20) of parents in the Netherlands and no parents in Germany
(see Table 3).
A large proportion of survey respondents (76%, 41/54)
agreed or strongly agreed that they left the hospital/
appointment feeling well informed about the condition.
However, 39% (21/54) agreed or strongly agreed that they
struggled to get access to specialists with the appropriate
knowledge and expertise initially (see Table 2). Respondents
living in Germany were much more likely to agree or strongly
agree with this statement (64%, 11/17) than respondents in the
UK (21%, 3/14) and the Netherlands (26%, 5/19).
Treating and Managing the Condition
Medicating Correctly The survey identified that the most com-
mon form of treatment was a combination of hydrocortisone
and fludrocortisone (78%, 32/41 of survey respondents report-
ed this combination).
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A large majority of parents who responded to the survey did
feel equipped to manage their child’s condition, they under-
stood how the medication worked and they felt confident to
respond appropriately in times of illness and emergency situa-
tions (see Table 2). In addition, 75% (33/44) of survey respon-
dents reported that their child’s condition and symptoms were
well controlled by their medication regime (scoring 8 or above
on a scale of 1 to 10). Yet, almost one third (30%, 13/44) of
survey respondents agreed or strongly agreed that the medica-
tion had to be given at inconvenient times and a similar num-
ber (32%, 14/44) agreed or strongly agreed that their sleeping
pattern was affected. The statement ‘I find it distressing giving
my child their medication’ elicited a total response of 59% (26/
44) disagreeing or strongly disagreeing. However, there ap-
pears to be a difference in responses between those living in
Germany and those in the UK/Netherlands, with only 19% (3/
16) of respondents in Germany disagreeing or strongly
disagreeing with the statement.
Delegating Care The survey highlighted a degree of reluc-
tance relating to delegating responsibility for the medica-
tion regime to others (see Table 2): 33% (16/48) disagreed
or strongly disagreed that they are happy for their child to
be cared for by others and 27% (13/48) agreed or strongly
agreed that they did not trust others to take responsibility
for their child’s medication.
Table 2 Survey responses: views in relation to diagnosis, medication and support
To what extent do you agree with the following statements? Strongly
agree
Agree Neither agree
nor disagree
Disagree Strongly
disagree
I don’t know/not
applicable
Views in relation to the diagnosis period (n = 54)
My child’s diagnosis was made quickly, % 48 28 7 6 11 0
We struggled to get access to specialists with the appropriate
knowledge and expertise, %
19 20 9 15 35 2
I left the hospital/appointment feeling well informed about
the condition, %
33 43 9 11 4 0
Views in relation to medication (n = 44)
I have been equipped with the appropriate skills and
knowledge to manage my child’s condition, %
36 50 7 5 2 0
I do not understand how the medication works, % 4 0 7 48 39 2
I know how to adapt my child’s medication in times of illness, % 57 41 2 0 0 0
I feel confident that I could respond appropriately in an
emergency situation (e.g. an adrenal crisis), %
32 43 14 4 0 7
I am happy for my child to be cared for by others, % 23 23 13 8 25 8
I do not trust others to take responsibility for my child’s
medication, %
16 11 25 37 9 2
Views in relation to practical and emotional support (n = 47)
I receive consistent information and advice from health
professionals, %
15 30 21 19 6 9
Medical professionals have a good awareness of the condition, % 25 32 19 9 13 2
I have been able to access all of the support and information
I need, %
30 36 19 9 4 2
Table 3 Survey responses: CAH/
AI initial symptoms or complica-
tions, by country
Initial symptoms or complications (frequency) UK Netherlands Germany Other Totala
Ambiguous genitalia 6 5 5 0 16
Dehydration/salt loss 6 3 4 1 14
Not applicable/no symptoms or complications 0 6 7 1 14
Hypoglycaemia 4 2 2 1 9
Adrenal crisis 6 2 0 1 9
Fatigue 4 1 1 1 7
Feeding problems 3 1 0 1 5
Physical development 1 1 1 0 3
Mood/behaviour difficulties 2 0 0 0 2
Total 16 20 18 3
aRespondents were able to tick more than one answer. N = 57
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Disruption to Family or Personal LifeApproximately 33% (16/
48) of survey respondents agreed or strongly agreed that their
personal time was interrupted as a result of their child’s con-
dition, and 50% (24/48) said they never forget that their child
has a chronic illness. Three quarters (75%, 33/44) of respon-
dents disagreed or strongly disagreed with the statement ‘the
medication stops us from doing things’. However, the propor-
tion of respondents living in Germany disagreeing or strongly
disagreeing with this statement was lower compared to those
in the UK and the Netherlands (50%, 8/16). Almost two thirds
of mothers (61%, 22/36) reported disruption fromwork some-
times or often compared to under half of fathers (45%, 5/11).
The survey found that patients required care from a variety of
healthcare professionals, including hospital doctors, general
practitioners and others. In the 57 returned surveys, 23
hospitalisations were reported (with median length of stay
for these hospitalisations being 3 days).
Thinking About the Future
A large majority (98%, 47/48) of respondents said they some-
times or often worry about their child’s future and almost half
(48%, 23/48) sometimes or often worry about their child
interacting with others.
Practical and Emotional Support
Although survey responses were mixed in relation to consis-
tency of advice received, a small majority of patients agreed
or strongly agreed that ‘medical professionals have a good
awareness of the condition’ (57%, 27/47) and that ‘I have
been able to access all of the support and information I need’
(66%, 31/47) (see Table 2). Fathers were more likely to agree
to the latter statement: 82% (9/11) of fathers agreed or strong-
ly agreed compared to 63% (22/35) of mothers. Survey data
revealed that generally parents were content with the support
they received in relation to their child’s surgery; 75% (12/16)
of respondents agreed or strongly agreed with the statement ‘I
felt well supported while making decisions about surgery’
and 69% (11/16) agreed or strongly agreed with the statement
‘I have received consistent advice and information about my
child’s surgery’. The high number of ‘I don’t know/not ap-
plicable’ responses to this question was excluded in the anal-
ysis on the assumption that most were ‘not applicable’ be-
cause surgery is not required for a significant proportion of
patients.
Respondents were asked to choose what types of support
they had accessed, beyond the supervising doctors. Only 14%
(8/57) reported that they had accessed professional psycholog-
ical support, and 19% (11/57) had accessed nurse specialists.
Larger numbers—but still a minority of respondents—had
sought support from patient or parent groups (37%, 21/57)
and online networks (39%, 22/57).
Discussion
This research has demonstrated that parents of young children
with AI face particular challenges as the primary caregivers in
relation to diagnosis, treatment, support and the future.
Diagnosis
The data provide insight into the difficulties that families face
prior to or during the diagnosis period and differences in ex-
periences across countries were observed. Such differences
have not been documented previously, as research focusing
on parents’ experiences of managing the childhood condition
has tended to recruit participants from a single country
(Fleming et al. 2017a). Awareness of specific rare diseases
amongst healthcare professionals is inevitably low, but as with
many rare diseases, parents’ experiences suggest that there is
probably variation across services in terms of awareness of
CAH and the ability to make a timely diagnosis.
The absence of a newborn screening test for CAHwithin the
UK’s NHSmeans that recognition of early clinical symptoms is
key. Research has shown CAH is associated with excess mor-
tality due to adrenal crisis (Falhammar et al. 2014; Swerdlow et
al. 1998) and therefore obtaining a speedy and accurate diag-
nosis is crucial. Many parents felt they had to fight to get the
attention of doctors and there was a lack of knowledge about
the condition amongst professionals, but this seemed to have
more impact in Germany. It is unclear why this should be the
case in Germany particularly, but it is of note that a survey of
the status of the paediatric endocrinology subspecialty under-
taken by the European Society of Paediatric Endocrinology in
2017 showed that both UK and Netherlands had well-
established subspecialty training and recognition, whereas
Germany had no approved subspecialty (Lebl et al. 2018).
Treating and Managing the Condition
The interview findings from the UK described at length par-
ents’ experiences in relation to the burden, disruption and latent
anxiety associated with the importance of dosing correctly.
Parents experienced a conflict between the pressure to medicate
at the right dose, and the requirement for them to (for example)
crush tablets of a larger dose, which is the general practice in the
UK. In the Netherlands and Germany, common practice is for
pharmacists to prepare the medicine. Such differences in prac-
tice may in part explain the variation of responses by country
which are suggested by the data. At the time of data collection,
and until very recently, there was no licenced treatment for
young patients hence the requirement to adapt adult prepara-
tions. Following a European Commission funded clinical trial,
a novel formulation of hydrocortisone has now been developed
and approved so that young patients with AI receive child-
appropriate doses (http://www.tain-project.org/).
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Survey responses arguably presented a more positive pa-
rental experience than interviewee accounts in relation to
medicating correctly. This could be attributed to the nature
of the two approaches to data capture. Interviews captured
parents’ journeys over time (i.e. their experiences from the
time of their child’s diagnosis to the present day), whereas
the survey captured a snapshot of parents’ views at the time
of completion of the survey. Almost 90% of survey respon-
dents had children over the age of one, and so their earliest
experiences of learning about and adapting to the regime may
not be reflected in their responses. The positive experiences
reported by parents may also reflect the simple fact that it is
possible to manage the condition through medication, unlike
many other rare conditions where access to treatments is very
limited (Muir 2016; Limb et al. 2010).
The interview and survey data suggest that over time
parents develop confidence and knowledge in relation to
managing the condition. However, the data also suggest
that it is common for parents to face difficulties in delegat-
ing care to others (such as staff in childcare settings or
schools), further adding to the burden they experience.
These findings are also consistent with previous research
focusing on parents’ management of adrenal crisis carried
out in the USA by Fleming et al. (2017b). The findings
have highlighted the importance of supporting parents to
better manage the delegation and transition of care to these
individuals.
The data demonstrate that parenthood is impacted to a
varying extent by the medical needs of affected children,
and this can be manifested in disruption to sleep, to daily
routines, to personal life and employment. Such disruption is
not surprising given the nature of the care giving role—taking
responsibility for an intensive medication regime and attend-
ing regular medical appointments. Due to the rarity of the
condition, families are likely to be required to travel some
distance to access specialist care and treatment. Again, the
survey responses were more positive in this respect than the
detail that emerged during interviews might have predicted.
The survey findings are consistent with the results of a ques-
tionnaire study on the functioning of children with CAH and
their parents in the Netherlands which found that experienced
burden of the condition is low and as children grow older,
parents become less afraid of adrenal crisis (Sanches et al.
2012). Again, this might be attributable to the adjustment
and coping mechanisms that parents adopt over time whereas
the disruption is likely to be more strongly felt in the imme-
diate period post-diagnosis which is a period represented in
the interview data but less so in the survey data. In addition,
appointments with specialists may be more frequent during
this time in order to establish appropriate care plans, and par-
ents may be more likely to seek advice from professionals
about their child’s symptoms and the appropriate course of
treatment during times of stress and illness.
Thinking About the Future
Parents reported concerns they have for their child in the fu-
ture and this finding was consistent across the interview and
survey data. As with other rare diseases, parents worry about
their children facing health challenges as they grow up, feeling
different to their peers (especially at school), and about wheth-
er the transition to care provided by adult health services will
be effective (Muir 2016; Limb et al. 2010). This latter concern
is borne out by an assessment of a UK endocrine centre which
found that half of all young people with CAH referred to the
specialist adult service between 3 and 10 years earlier were no
longer attending (Gleeson et al. 2013).
Practical and Emotional Support
Interview and survey data around the support received
from ‘medical professionals’ (as a general description)
were consistent in that both gave a mixed review about
of the levels of knowledge about the condition. It is an
unavoidable feature of rare diseases that specialists are
scarce, and the lack of knowledge amongst professionals
providing health services locally is a common challenge
for rare disease patients (Limb et al. 2010).
Interviewees reported positive experiences with psycholo-
gy support services, but the survey data show that very few
families had access to this kind of support; parents’ concerns
revealed in the interviews are wide ranging and a source of
anxiety and demonstrate the need for parents (not only pa-
tients) to be better supported psychologically to come to terms
with the diagnosis, make difficult decisions about surgery and
to communicate with others about the condition. This finding
is consistent with other research with parents in the UK and
Sweden which concludes that parents face diverse challenges,
requiring support which addresses other skills beyond manag-
ing the condition (Lundberg et al. 2016).
Interviewees reported the value of connecting with other
families to share experiences and practical advice. Perhaps
surprisingly, the survey data indicate that a minority of partic-
ipants in this study access this kind of contact and support
despite most participants being recruited via patient organisa-
tions. As such, a case could be made for increasing the reach
of such peer support activities. In part, this finding may also
reflect how parents’ confidence and ability to manage their
child’s condition develops over time.
In light of these gaps in support provision, there is some
reassurance in the finding that two thirds of survey respon-
dents felt that they had been able to access all the support and
information they need. Interestingly, a higher proportion of
fathers compared to mothers felt they had been able to access
all of the support and information they required. Mothers are
more likely to be at home with their child during maternity
leave and as such are more often the primary caregivers
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responsible for daily monitoring and treatment of the condi-
tion during the early months of their child’s life. In addition,
higher proportions of mothers reported disruption to their
work. Tailored support should be provided for new mothers
in their caring role and in helping them transition back to work
when they are ready.
Implications for Healthcare Providers
A number of the findings have implications for healthcare
professionals. In the UK, the lack of a screening programme
meant 38% of newborns presented with an adrenal crisis,
which was distressing for the parents and is likely to have
had a long-term impact on their view of the condition.
Ironically though, this may have helped them to access spe-
cialists sooner than parents in Germany. It is important in
healthcare systems that awareness around adrenal crises is
improved and that there is a pathway for rapid referral to
clinicians with experience in treating adrenal failure. Genetic
counsellors have a role in talking with families about the re-
currence risk for future children and previous research has also
highlighted the importance of their role in supporting parents
to communicate with other family members following diag-
nosis (Abad et al. 2017). Such support may be crucial in iden-
tifying others at risk and ensuring early diagnosis.
The study identified that although parents gain confidence
and adjust over time, they face particular challenges following
a diagnosis. Good support and communication with parents
during the diagnosis period is important to start to equip them
with the confidence, knowledge and skills they will need as
primary carers of a child with AI. For parents of a child with
AI who are expecting or planning another baby, genetic coun-
sellors have an opportunity to ameliorate concerns the parents
may have around management of a newborn. Sensitive han-
dling of these discussions will need to take into account the
early experiences of the parents with their existing affected
child, which may have been traumatic. They can work with
parents to ensure they understand the timing and nature of the
diagnostic tests that will be carried out with their newborn, as
well as addressing questions about ongoing care.
Parents were concerned with the challenge of delegating
care and understanding what the future held for their child.
These concerns need to be addressed by all healthcare profes-
sionals but especially through informed psychological support
which should be provided to both child and parents throughout
childhood, particularly in the period post-diagnosis. More spe-
cifically, psychosocial support is required for those families
whose child is born with ambiguous genitalia and those faced
with complex decisions about surgery. A multidisciplinary, ho-
listic approach, is required to meet the needs of these families.
A challenge for any congenital chronic disease is the impact
on the family of frequent hospital visits as well as the require-
ment to take complex medication and this was reported in this
study. Healthcare professionals need to optimise their service to
take into account the needs of the family, and treatment regi-
mens need to be as simple as possible and supported by training
to reduce parental anxiety around preparation and dosing.
Study Limitations and Strengths
Survey response numbers are small so the quantitative analy-
sis was restricted to descriptive statistics. However, together
the two approaches triangulate the data and provide a more
detailed insight into experiences than studies which employ a
single method. The mixed methods approach also offers a
better understanding of how parents’ experiences might
change over time. The survey is a new instrument, based on
our interview findings. As such, statistical comparisons can-
not be made with research with other populations. The major-
ity of participants were recruited via support organisations
which may be considered to bias the findings. Further research
is required to reach a wider range of families in order to guide
development of resources and support for all families.
The key value of our study is that it provides an insight into
the wider impact of the condition, beyond a clinical and bio-
medical focus, in three countries using a mixed methods ap-
proach. The content and focus of the survey were guided by the
themes that emerged from the voice of interviewees in phase 1.
Researchers have claimed that the views of those affected by
rare conditions have been neglected within research (Huyard
2009) and little is known about the wider impact on families of
children with rare diseases (Dellve et al. 2006). Such an ap-
proach can provide insights into the social context in which
participants live (Shah and Priestley 2011) and can identify
unmet needs and issues within health services and ultimately
lead to improvements (Thorne et al. 2002; Ziebland et al.
2013).
The study complements and builds on other research with
parents of children with AI/CAH. Given that previous work
has identified that parents of children under five feel less able
to manage the condition than those with older children
(Fleming et al. 2017b), the study offers a valuable perspective
by focusing on the experience within the first 6 years of par-
enthood and provides key insights across four key themes:
diagnosis, treatment, support and the future. Previous studies
have also been limited in their methods—this mixed methods
study recruited parents from both support groups and endocri-
nologist clinics across three different countries offering a
broader viewpoint.
Future Research
Using the survey tool developed in this study, future research
should focus on capturing the experiences of patients and
families using the health systems of other countries, and with
those who may be less engaged with support organisations, to
Simpson et al.
guide the development of better support for families. Given
the importance of good daily management of AI/CAH
throughout life, further research is needed around the experi-
ence of patients and families during transition of care from
parents to other adults (such as in childcare settings); from
parents to self-management by the maturing patient; and from
child to adult health services. Such research could have an
important impact on improving long-term health outcomes.
Conclusions
This study provides a unique and detailed insight into the
impact of living with and managing AI, from the perspective
of parents of affected young children in three European coun-
tries. It shows that although parents do adjust and gain confi-
dence as caregivers over time, they face a particular burden
which is associated with challenges during the diagnosis peri-
od; managing and treating the condition; thinking about their
child’s future; and access to practical and emotional support.
The burden on parents could be reduced, and potentially the
health outcomes for their children improved, by raising aware-
ness of the condition amongst healthcare professionals; devel-
oping treatment regimens which are easier and less disruptive
to administer; and providing better practical and emotional
support, including peer-to-peer and professional psychologi-
cal support. The findings of the study reinforce the need for
genetic counselling to address the issue of diagnosis sensitive-
ly when parents are planning or expecting further children.
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